KANGSTEM BIOTECH CO., LTD.KANGSTEM BIOTECH CO., LTD.KANGSTEM BIOTECH CO., LTD.

KANGSTEM BIOTECH CO., LTD.

No trades
See on Supercharts

217730 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

KANGSTEM BIOTECH Co., Ltd. engages in the development and manufacture of stem cell therapy. It operates through the Stem Cell, Cosmetics, and Biopharma business divisions. The Stem Cell division focuses on separating multi-functional stem cells from human umbilical cord. The Cosmetics division sells products based on stem cell culture fluid. The Biopharma division engages in the wholesale distribution of pharmaceuticals. Its products include muscle pain treatment and toothpaste type gum medicine. Its services include next generation and gene-loaded stem cell. The company was founded by Kyung-Sun Kang on October 29, 2010 and is headquartered in Seoul, South Korea.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

217730 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company